In pancreatic cancer, Cheng et al. revealed concurrent TNS2 and AXL upregulation in pancreatic ductal adenocarcinoma (PDAC) through tumor tissue microarray analysis of 33 patients, supported by in vitro evidence [123]. This evidence concerns the gene TNS2 and neoplasm.